By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TB Alliance 

40 Wall Street
24th Floor
New York  New York  10005  U.S.A.
Phone: 212-227-7540 Fax: 212-227-7541



Company News
TB Alliance Sublicenses Promising Anti-Tuberculosis Drug From The Medicines Patent Pool 3/27/2017 9:27:48 AM
TB Alliance And Takeda (TKPYY) Announce Advancement Of Joint Program Investigating Promising Compounds For Novel TB Therapies Through Global Health Innovative Technology Fund 6/22/2016 11:15:44 AM
TB Alliance And The Medicines Patent Pool Sign Memorandum Of Understanding To Improve Access To TB Medicines In Resource-Limited Nations 4/20/2016 9:36:35 AM
TB Alliance And Partners Announce World's First Availability Of Appropriate, Child-Friendly TB Medicines In Correct Doses 12/2/2015 6:50:48 AM
TB Alliance Launches "Nix-TB" Clinical Trial To Test New XDR-TB Treatment 5/14/2015 11:09:57 AM
Australia Grants Support For TB Alliance To Advance New TB Drugs 3/25/2015 7:33:22 AM
TB Alliance Announces Partnership With U.S. Fund For UNICEF To Increase Access To Impending New Child-Friendly TB Treatments 3/24/2015 9:44:47 AM
TB Alliance Advances Next-Generation TB Drug Candidate Into Clinical Testing 2/19/2015 8:57:05 AM
TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 7/31/2014 10:01:54 AM
TB Alliance Names Elana Robertson Senior Vice President, Market Access 7/31/2014 10:00:51 AM